Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC408

Aciminib eða lyfjafræðilega viðunandi salt þar af, á borð við asciminibhýdróklóríð

  • Status:
    Veitt
  • Application date:
    24.10.2022
  • Application published:
    15.11.2022
  • Grant published:
    15.1.2025
  • Max expiry date:
    25.8.2037
  • Medicine name:
    Scemblix
  • Medicine for children:
    No

Timeline

Today
24.10.2022Application
15.11.2022Publication
15.1.2025Registration
25.8.2037Expires

Marketing license

  • IS authorization number:
    EU/1/22/1670/001-002; EU/1/22/1670/003-004
  • Date:
    30.8.2022
  • Foreign authorization number:
    EU/1/22/1670
  • Date:
    25.8.2022

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, Basel CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Deadlines

TypeDeadline until

Type: Frestur til að fara yfir drög að vottorði

Deadline until: 11.01.2025

Upload documents